Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 22Observational 1

Sponsor

Cancer Type

Thoracic 1Genitourinary 1Dermatologic 1

Conditions

Colorectal Neoplasms 30Carcinoma, Non-Small-Cell Lung 9Breast Neoplasms 7Carcinoma, Renal Cell 6Carcinoma, Hepatocellular 6Lung Neoplasms 5Ovarian Neoplasms 4Colorectal Cancer Metastatic 3Colonic Neoplasms 3Adenocarcinoma of Lung 3Rectal Neoplasms 2Neoplasms 2Neoplasm Metastasis 2Liver Neoplasms 2Financial Stress 2Brain Neoplasms 2Adenocarcinoma, Bronchiolo-Alveolar 2Unspecified Adult Solid Tumor, Protocol Specific 1Unresectable Hepatocellular Carcinoma 1Surgical Wound Infection 1Non-Squamous Non-Small Cell Lung Cancer 1Neuroma, Acoustic 1Neurofibromatosis 2 1NSCLC 1Melanoma 1Kidney Neoplasms 1Hypertension 1Hemorrhage 1Glioblastoma 1Feasibility 1

Interventions

Gene Expression Profiling 9Blood Specimen Collection 6Polymerase Chain Reaction 5Immunohistochemistry 5Amplified Fragment Length Polymorphism Analysis 5Surveys and Questionnaires 3Sunitinib 3Reverse Transcriptase Polymerase Chain Reaction 3Flow Cytometry 3Biopsy 3Surgical Procedures, Operative 2Radiotherapy 2Radiosurgery 2Patient Reported Outcome Measures 2Observation 2Nivolumab 2Microarray Analysis 2Immunotherapy 2Genetic Testing 2Drug Therapy 2DNA Methylation 2Cytogenetic Analysis 2tremelimumab 1pembrolizumab 1durvalumab 1atezolizumab 1aldesleukin 1X-Rays 1Watchful Waiting 1Tomography, Optical Coherence 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Kidney Neoplasms × Bevacizumab × Clear all
NCT04107168 2023-02-16

Microbiome Immunotherapy Toxicity and Response Evaluation

Cambridge University Hospitals NHS Foundation Trust

Unknown
1,800 enrolled
DermatologicGenitourinaryThoracic

Kidney Neoplasms, Lung Neoplasms, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡